��ժҪ��Ϣ

[an error occurred while processing this directive]

��Ƥ��Բ�ѧ��־ 2003, 29(1) 20-22 DOI: ISSN: 2096-5540 CN: 32-1880/R

��Ŀ¼ | ��Ŀ¼ | �� | �߼�� [��ӡ��ҳ] [�ر�]

��

	��չ��

	��Ϣ
	Supporting info
	PDFȫ��
	[HTMLȫ��]
	�ο��
	��뷴��
	�ѱ��Ƽ��
	��ҵ��
	��ù��
	��ñ��
	Email Alert
	��·��
	��Ϣ
	��Ĺؼ��
	��Ǵ�,ϵͳ��
	��آ��
	��-��
	��Ȼ��-��ϸ��
	SLE-IFN�յ��
	��
	��
	��ѧ��
	PubMed
	Article by ��
	Article by ��ѧ��

��͸��ϵͳ��ϵͳ�Ժ��Ǵ��е��

��¹, ��ѧ��²

1. ��ݾ��ҽԺƤ��, �� 510010;
2. ��һ��ҽ��ѧ�Ϸ�ҽԺƤ��

ժҪ��

��ص��߸��Ϊ��Եĸ��-��յ��,��Դ��ص��,��¸��ĸ��-��,��͸��ϵͳͨ��һ��ѭ��ά��߹��,��ϵͳ�Ժ��Ǵ��ķ��֧��.��-��յ��ﱻ��Ļ��ʱ,��-��ֹͣ,��߹��½�.��ˢ��͸��ϵͳ��Ƽ��ϵͳ�Ժ��Ǵ��Чҩ��.

�ؼ���� Ǵ�,ϵͳ�� آ�� -�� Ȼ��-��ϸ�� SLE-IFN�յ��

1. ��ݾ��ҽԺƤ��, �� 510010;
2. ��һ��ҽ��ѧ�Ϸ�ҽԺƤ��

Abstract:

Keywords:

�ո�� 2002-02-27 �޻�� ��淢��

DOI:

��Ŀ:

ͨѶ��:

��߼��:

�ο��ף�

[1] Lindqvist AK,Alarcon-Riquelme ME.The genetics of systemic lupus erythematosus.Scand J Immunol,1999,50(6);562-571.
[2] Bengtsson AA,Stuffelt G,Truedsson L,et al.Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies.Lupus,2000,9(9):664-671.
[3] Kalkner KM,Ronnblom L,Karlsson Parra AK,et al.Antibodies against double-stranded DNA and development of polymyositis during treatment with interferon.QJM,1998,91(6);393-399.
[4] Ioannou Y,Isenberg DA.Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy.Arthritis Rheum,2000,43(7):1431-1442.
[5] Akbar AN,Lord JM,Salmon M.IFN-alpha and IFN-beta:a link between immune memory and chronic inflammation.Immunol Today,2000,21(7);337-342.
[6] Santini SM,Lapenta C,Logozzi M,et al.Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.J Exp Med,2000,191(10);1777-1788.
[7] Siegal FP,Kadowaki N,Shodell M,et al.The nature of the principal type 1 interferon-producing cells in human blood.Science,1999,284(5421);1835-1837.
[8] Cella M,Jarrossay D,Facchetti F,et al.Plasmacytoid monocytes migrate to intlamed lymph nodes and produce large amounts of type �� interferon.Nat Med,1999,5(8);919-923.
[9] Cederblad B,Blomberg S,Vallin H,et al.Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha-producing cells.J Autoimmun,1998,11(5):465-470.
[10] Vallin H,Blomberg S,Alm GV,et al.Patients with systemic lupus erythematosus(SLE)have a circulating inducer of interferon-alpha(IFN-alpha)production acting on leucocytes resembling immature dendritic cells.Clin Exp Immunol,1999,115(1):196-202.
[11] Vallin H,Perers A,Alm GV,et al.Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus.J Immunol,1999,163(11);6306-6313.
[12] Lehtonen A,Matikainen S,Julkunen I.Interferons up-regulate STAT1,STAT2,and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages.J Immunol,1997,159(2);794-803.
[13] Sato Y,Miyata M,Sato Y,et al.CpG motif-containing DNA fragments from sera of patients with systemic lupus erythematosus proliferate mononuclear cells in vitro.J Rheumatol,1999,26(2):294-301.
[14] Narumi S,Takeuchi T,Kobayashi Y,et al.Serum levels of IFN-inducible protein-10 relating to the activity of systemic lupus erythematosus.Cytokine,2000,12(10);1561-1565.
[15] Voll RE,Hemnann M,Roth EA,et al.Immunosuppressive effects of apoptotic cells.Nature,1997,390(6658);350-351.
[16] Herrmann M,Voll RE,Kalden JR.Etiopathogenesis of systemic lupus erythematosus.Immunol Today,2000,21(9);424-426.
[17] Payvandi F,Amrute S,Fitzgerald-Bocarsly P.Exogenous and endogenous IL-10 regulate IFN-alpha production by peripheral blood mononuclear cells in response to viral stimulation.J Immunol,1998,160(12);5861-5868.
[18] Dean GS,Tyrrell-Price J,Crawley E,et al.Cytokines and systemic lupus erythematosus.Ann Rheum Dis,2000,59(4);243-251.
[19] Tsokos GC,Kammer GM.Molecular aberrations in human systemic lupus erythematosus.Mol Med Today,2000,6(11);418-424.

��е��

1��, ��, �˵��.��ϸ��-1��ϵͳ�Ժ��Ǵ�[J]. ��Ƥ��Բ�ѧ��־, 2007,33(6): 349-351

2��Ƽ, ��, ��ɭ, ��ѧ��.��ͯϵͳ�Ժ��Ǵ��Ľ�չ[J]. ��Ƥ��Բ�ѧ��־, 2007,33(6): 352-354

3��,��ѧ��.��ص��Ӽ��SLE[J]. ��Ƥ��Բ�ѧ��־, 2008,34(4): 224-226

4��,��.ϸ��T�ܰ�ϸ��ؿ�ԭ-4��SLE[J]. ��Ƥ��Բ�ѧ��־, 2008,34(6): 382-384

5��С��,��,��ٺ�.DNA�׻�ת��ø��SLE��Ŵ��е��[J]. ��Ƥ��Բ�ѧ��־, 2009,35(2): 90-92

6��ɺ ��.��Ƥ�ʼ��SLE��Ӧ�ķ��ӻ��[J]. ��Ƥ��Բ�ѧ��־, 2009,35(3): 145-147

7��ͥ�� ֣��.��ϰ��ϵͳ�Ժ��Ǵ�[J]. ��Ƥ��Բ�ѧ��־, 2006,32(6): 353-353

8��, ��긻.ϵͳ�Ժ��Ǵ�Ԥ��Ӱ��[J]. ��Ƥ��Բ�ѧ��־, 0,(): 358-360

9��½��, ½��֮��У.SLE��о��չ[J]. ��Ƥ��Բ�ѧ��־, 1995,21(1): 7-9

10��ߴ��, ��У.ϵͳ�Ժ��Ǵ�С��ģ�͵��о��[J]. ��Ƥ��Բ�ѧ��־, 1995,21(4): 211-214

11��, ��У.C-mycԭ��ϵͳ�Ժ��Ǵ�[J]. ��Ƥ��Բ�ѧ��־, 1995,21(4): 214-217